CORUNDUM SYSTEMS BIOLOGY APPOINTS JESSICA SCHNEIDER AS CHIEF SCIENTIFIC OFFICER
Former Takeda Ventures Director Joins Investment Company to Spur Systems Biology Business Creation and Innovation TOKYO, Sept. 4, 2024 /PRNewswire/...
Pharmaceutical
Pharma Targeting celebrates a year of growth and milestones amid industry challenges
Customised consultancy and revolutionary 3 Step Model brings global growth for company and its booming client base LONDON, Sept. 4,...
Phesi Receives Frost & Sullivan’s Global Enabling Technology Leadership Award for Revolutionizing Clinical Development with Its Trial Accelerator Platform
Phesi's Trial Accelerator™ Platform empowers trial sponsors to make informed decisions swiftly, expediting drug development timelines while upholding the highest...
Royal Society Hosts BioAro’s UK Launch in Partnership with Golden Helix Foundation to Enhance Genomic Medicine Education
NEW YORK, Sept. 4, 2024 /PRNewswire/ -- BioAro successfully launched its presence in the UK at the Royal Society on August 29th,...
Constantiam Biosciences Secures $2.05M Phase II SBIR Grant from NHGRI to Advance Functional Analysis Platform for Variants of Uncertain Significance (VUS)
HOUSTON, Sept. 4, 2024 /PRNewswire/ -- Constantiam Biosciences, a startup focused on powering genomic medicine, is pleased to announce that...
HealthVerity introduces taXOnomy℠, the nation’s most comprehensive closed (X) and open (O) claims dataset for pharmaceutical research
PHILADELPHIA, Sept. 4, 2024 /PRNewswire/ -- HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the...
Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials network
Emmes, part of Emmes Group, today announced they will provide a Clinical Coordinating Center for the NIH's National Institute on...
Caris Life Sciences to Showcase Research Highlighting the Clinical Value of Comprehensive Molecular Profiling at ESMO 2024
In collaboration with leading cancer centers, research results to be presented from seven studies across a wide range of tumor...
Waterdrop Inc. Announces Second Quarter 2024 Unaudited Financial Results and a Special Cash Dividend
BEIJING, Sept. 4, 2024 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated...
Compassion Center Urges DEA to Reschedule Cannabis to Schedule III During December 2, 2024, Hearing
Compassion Center urges the DEA to reschedule cannabis to Schedule III of the Controlled Substances Act during the December 2,...
Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry
Current Test Positivity Rate for Coronavirus Infection in the U.S. is 18%Development of a novel antiviral compound, XR8-23 (Compound 10),...
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications
MIAMI, FL / ACCESSWIRE / September 4, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a pre-clinical-stage company...
As Research into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront – Tonix Targets it with FDA-Fast Track-Designated TNX-102 SL
CHATHAM, NJ / ACCESSWIRE / September 4, 2024 / This post was written and published as a collaboration between the...
Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
ORLANDO, FL / ACCESSWIRE / September 4, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has reported its financial results for the second...
GRI Bio to Present at the 2024 European Respiratory Congress
LA JOLLA, CA, Sept. 04, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a...
Next Generation Medical Writing Course: A 14-week, trainer-led, online, specially curated medical writing certificate course by Turacoz
DUBAI, UAE and RIYADH, Saudi Arabia and NEW DELHI, Sept. 4, 2024 /PRNewswire/ -- The global medical writing market is...
IRLAB is Granted Additional Patent for Drug Candidate Mesdopetam that Expands its Patent Protection
GOTHENBURG, SWEDEN / ACCESSWIRE / September 4, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, September 4, 2024 - IRLAB Therapeutics...
10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research
PLEASANTON, Calif., Sept. 3, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today...
ProofPilot Bolsters Advisory Board with Appointment of Michelle Everill
NEW YORK, Sept. 3, 2024 /PRNewswire/ -- ProofPilot, the leading Clinical Experience Platform (CXP) that centralizes and simplifies communication for...
EnClear Therapies, Inc. Secures Additional Funding to Advance Neuro-Oncology Innovations
Support from the Brain Tumor Investment Fund, a subsidiary of the National Brain Tumor Society, and Sontag Innovation Fund Strengthens...